Work

Targeted Next-Generation Sequencing Reveals Clinically Actionable BRAF and ESR1 Mutations in Low-Grade Serous Ovarian Carcinoma

Year: 2018

Type: article

Source: JCO Precision Oncology

DOI: 10.1200/po.18.00135

Authors: Elizabeth H. Stover, Colleen Feltmate, Ross S. Berkowitz, Neal I. Lindeman, Ursula A. Matulonis, Panagiotis A. Konstantinopoulos

Institutions: Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Dana-Farber Brigham Cancer Center

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Funders: Harvard Catalyst, National Institutes of Health, National Center for Advancing Translational Sciences

Awards: G1485268950, G5457525012, Harvard Clinical and Translational Science Center, G994665467

OpenAlex ID: W2899764404

FWCI: 1.609

Cites: 42

Cited by: 12

Related to: 10